News

• 14 May 2013
  Amongst the best in cancer and metastasis studies

  The journal Cancer Cell ranks the article on colon cancer metastasis by Eduard Batlle and Elena Sancho among the best 10 in 2012.

• 3 May 2013
  How to get natural products “from the lab”

  A new technique from IRB Barcelona combines chemistry and biology to produce an exact copy of the natural molecule Thiocoraline.

  Thiocoraline is a potent anti-cancer agent that is chemically very complex. It was isolated by PharmaMar from the actinobacteria Micromonospora marina, which in turn was isolated in 1997 from a sea sponge from the Indian Ocean.

• 23 April 2013
  Where is medicine headed?

  IRB Barcelona participates for the ninth time in the “Live Research” Fair, an event held in La Pedrera in Barcelona that seeks to bring science closer to the general public.

• 22 April 2013
  Doing business in Chicago

  IRB Barcelona participates in the BIO International Convention, the main international meeting for biotechnology

• 19 April 2013
  An IRB Barcelona study contributes to the understanding and prevention of the side effects caused by drugs
  • This is the first study that studies and quantifies 1,600 known adverse effects of drugs currently on the market.
  • The scientists Miquel Duran and Patrick Aloy provide a description of the molecular processes responsible for more than 1,000 secondary effects.
  • This knowledge, which is available to the scientific community, may be of great use to minimize and predict adverse effects during drug design.

• 17 April 2013
  Xavier Salvatella receives an award from the Spanish Biophysics Society
• 12 April 2013
  Presentation of CancerTec, a programme to boost the added value of cancer research

  Thanks to the support from "Generalitat de Catalunya" and "Obra Social la Caixa", the Institute launches CancerTec, an initiative to identify and develop in a continuous and dynamic manner cancer projects identified as having potential economic impact.

  Through its first call, CancerTec is funding four IRB Barcelona projects with possibilities of their results being transferred to industry in the form of new diagnostic tools and more efficient and innovative cancer treatments.

• 11 April 2013
  IRB Barcelona students to explain to secondary school students the use of radiotherapy in cancer treatment

  The Genomic Instability and Cancer Laboratory participates in the 3rd Knowledge Fair of Berga, an event promoted by the UPC and the UB and supported by the Berga Town Council and the Ministry of Education.

• 26 March 2013
  Proteins in detail

  IRB Barcelona scientists pave the way towards describing the conformation of proteins that do not have a defined structure

  Structural and theoretical techniques are combined to develop new methodologies for the analysis of proteins.

• 25 March 2013
  IRB Barcelona participates in the resolution of the first structures achieved with the Alba synchrotron

  Joan Roig’s team collect three-dimensional information of protein complexes involved in cell division.